ImmunityBio, Inc. IBRX Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by ImmunityBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The official record: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about ImmunityBio, Inc.'s total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ImmunityBio, Inc.'s total assets?
- ImmunityBio, Inc. (IBRX) reported total assets of $646.64M in Q1 2026.
- How has ImmunityBio, Inc.'s total assets changed year-over-year?
- ImmunityBio, Inc.'s total assets increased by 112.9% year-over-year, from $303.76M to $646.64M.
- What is the long-term trend for ImmunityBio, Inc.'s total assets?
- Over 5 years (2020 to 2025), ImmunityBio, Inc.'s total assets has grown at a 17.8% compound annual growth rate (CAGR), from $221.38M to $501.9M.
- What does total assets mean?
- The total value of everything the company owns, including cash, equipment, and intellectual property.
- How do you interpret total assets?
- An increase generally reflects growth in the company's resource base, while a decrease may indicate asset liquidation or significant impairment.
- How does total assets compare across companies?
- Used to compare the overall scale and capital intensity of biotech companies within the industry.